While Cassava is stopping investigations into simufilam in Alzheimer’s disease, the therapy is now being evaluated in ...

The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infections (uUTIs) in adult females and ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced new monthly safety bulletins aimed at making ...

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

Character Biosciences has raised $93m in an oversubscribed Series B funding round to expedite the progression of precision ...

Sanofi will commence a Phase I/II trial with its vaccine candidate in the next few days to start generating immunogenicity ...

MSD has entered an exclusive licence agreement with Hengrui Pharma for the oral small molecule Lp(a) inhibitor, HRS-5346.

The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

Novo Nordisk has acquired the global rights to United Laboratories’ triple-agonist weight-loss and diabetes drug in a deal ...